Adipokine apelin ameliorates chronic colitis in Il-10-/- mice by promoting intestinal lymphatic functions.

Abstract

Both mesenteric adipose tissue (MAT) and lymphatic vessels (LVs) play important roles in the pathogenesis of Crohn's disease (CD), and adipokines have been implicated in the crosstalk between MAT and LVs. Apelin, a newly identified adipokine, has been demonstrated to be crucial in the development and stabilization of LVs. We aimed to identify the expression of apelin in MAT of CD patients and explore whether apelin influences the disease course in murine colitis and determine its contributions to LVs. Expression of apelin in MAT specimens from patients with CD (n = 24) and without CD (control, n = 12) was detected. Il-10 deficient (Il-10-/-) mice with established colitis were administered apelin, and untreated and wild-type mice served as controls (n = 8 for each group). Disease activity and colonic inflammation was evaluated. The LV density, lymphatic drainage function and related signaling pathways were also analyzed. We found that MAT from CD patients expressed a higher level of apelin compared with that from controls. Systemic delivery of apelin significantly ameliorated chronic colitis in Il-10-/- mice, demonstrated by decreased disease activity index and inflammatory scores, and lower levels of Tnf-α, Il-1β and Il-6. Increased LV density and podoplanin levels indicated that apelin promoted lymphangiogenesis. Evans blue dye and fluorescent lymphangiography revealed an enhanced lymphatic drainage function in apelin-treated mice. The role of apelin was found to be related to the activation of the Akt and Erk signaling pathways. These results indicate that the adipokine apelin was highly expressed in MAT of CD patients and has a promising role in ameliorating experimental colitis by promoting intestinal lymphatic functions, suggesting the potential crosstalk between adipokines and LVs in MAT in CD status. Therapies with adipokines, such as apelin, may be a novel approach for the treatment of CD.

• Authors: Yuanyuan Ge, Yi Li, Qin Chen, Weiming Zhu, Lugen Zuo, Zhen Guo, Jianfeng Gong, Lei Cao, Lili Gu, Jieshou Li
• Journal: Biochemical pharmacology (Biochem Pharmacol) Vol. 148 Pg. 202-212 (02 2018) ISSN: 1873-2968 [Electronic] England
• PMID: 29309764 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2018. Published by Elsevier Inc.

Chemical References

• Apelin
• Interleukin-10

Topics

• Adipose Tissue (metabolism)
• Animals
• Apelin (metabolism, pharmacology)
• Case-Control Studies
• Colitis (drug therapy, genetics)
• Crohn Disease (metabolism, pathology)
• Gene Expression Regulation
• Genetic Predisposition to Disease
• Humans
• Interleukin-10 (genetics, metabolism)
• Intestines (drug effects)
• Lymphatic System (drug effects)
• Male
• Mice
• Mice, Knockout